rdf:type |
|
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0016030,
umls-concept:C0017262,
umls-concept:C0178539,
umls-concept:C0185117,
umls-concept:C0214897,
umls-concept:C0379710,
umls-concept:C0392756,
umls-concept:C0871261,
umls-concept:C1335671,
umls-concept:C1506219,
umls-concept:C1704256,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911684,
umls-concept:C2911692
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-6-13
|
pubmed:abstractText |
Transcriptional repression of Transforming Growth Factor-beta type II receptor (TbetaRII) gene has been proposed to be one of the major mechanisms leading to TGF-beta resistance. In this study, we demonstrate that expression of Caveolin-1 (Cav-1) gene in NIH3T3 fibroblast cells down-regulates the expression of TbetaRII gene in the transcriptional level, eventually resulting in the decreased responses to TGF-beta. The reduced expression of TbetaRII gene by Cav-1 appeared to be due to the changes of the sequence-specific DNA binding proteins to either Positive Regulatory Element 1 (PRE1) or PRE2 of the TbetaRII promoter. In addition, Cav-1 expression inhibited TGF-beta-mediated cellular proliferation and Plasminogen Activator Inhibitor (PAI)-1 gene expression as well as TGF-beta-induced luciferase activity. Furthermore, the inhibition of endogeneous Cav-1 by small interfering RNA increased the expression of TbetaRII gene. These findings strongly suggest that expression of Cav-1 leads to the decreased cellular responsiveness to TGF-beta through down-regulating TbetaRII gene expression.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-291X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
359
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
385-90
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17543885-Animals,
pubmed-meshheading:17543885-Binding, Competitive,
pubmed-meshheading:17543885-Caveolin 1,
pubmed-meshheading:17543885-DNA,
pubmed-meshheading:17543885-Down-Regulation,
pubmed-meshheading:17543885-Fibroblasts,
pubmed-meshheading:17543885-Gene Expression Regulation,
pubmed-meshheading:17543885-Mice,
pubmed-meshheading:17543885-NIH 3T3 Cells,
pubmed-meshheading:17543885-Promoter Regions, Genetic,
pubmed-meshheading:17543885-Protein Binding,
pubmed-meshheading:17543885-Protein-Serine-Threonine Kinases,
pubmed-meshheading:17543885-RNA, Small Interfering,
pubmed-meshheading:17543885-Receptors, Transforming Growth Factor beta,
pubmed-meshheading:17543885-Transcription, Genetic,
pubmed-meshheading:17543885-Transforming Growth Factor beta1
|
pubmed:year |
2007
|
pubmed:articleTitle |
Expression of Caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells.
|
pubmed:affiliation |
Inha University College of Medicine, Incheon, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|